Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Claudia Rauh
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes
Breast Care
Surgery
Oncology
Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry
Geburtshilfe und Frauenheilkunde
Gynecology
Midwifery
Maternity
Obstetrics
Related publications
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes
Impact of the Tumor Microenvironment on Tumor-Infiltrating Lymphocytes: Focus on Breast Cancer
Breast Cancer: Basic and Clinical Research
Cancer Research
Oncology
Clinical Significance of Tumor-Infiltrating Lymphocytes in Breast Cancer
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Neoepitope Targets of Tumour-Infiltrating Lymphocytes From Patients With Pancreatic Cancer
British Journal of Cancer
Cancer Research
Oncology
Multi-Panel Immunofluorescence Analysis of Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer: Evolution of Tumor Immune Profiles and Patient Prognosis
PLoS ONE
Multidisciplinary
Distribution of CD4+ and CD8+ Exhausted Tumor-Infiltrating Lymphocytes in Molecular Subtypes of Chinese Breast Cancer Patients
OncoTargets and Therapy
Oncology
Pharmacology
Prognostic Value of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
BMC Cancer
Cancer Research
Oncology
Genetics
Correlation Between Mammographic Radiomics Features and the Level of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer
Frontiers in Oncology
Cancer Research
Oncology
Intrinsic Prognostic Impact of Tumor-Infiltrating Lymphocytes in Systemically Untreated Patients With Early-Stage Triple-Negative Breast Cancer
Anticancer Research
Medicine
Cancer Research
Oncology
